Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Trends in non-receipt of recommended chronic obstructive pulmonary disease medication

Michael Poon, Priscila Pequeno, Shawn D. Aaron, Matthew Stanbrook, Harvey Wong, Peter Cram, Andrea S. Gershon
ERJ Open Research 2021; DOI: 10.1183/23120541.00584-2021
Michael Poon
1Department of Medicine, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priscila Pequeno
2ICES, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn D. Aaron
3Ottawa Health Research Institute, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Stanbrook
1Department of Medicine, University of Toronto, Toronto, ON, Canada
2ICES, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harvey Wong
1Department of Medicine, University of Toronto, Toronto, ON, Canada
4Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Cram
1Department of Medicine, University of Toronto, Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Cram
Andrea S. Gershon
1Department of Medicine, University of Toronto, Toronto, ON, Canada
2ICES, Toronto, Ontario, Canada
4Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea S. Gershon
  • For correspondence: andrea.gershon@ices.on.ca
  • Article
  • Info & Metrics
  • PDF
Loading

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of Interest: Mrs. Pequeno has nothing to disclose.

Conflict of Interest: Dr. Aaron reports personal fees from GSK, personal fees from Sanofi, personal fees from Astra Zeneca, outside the submitted work.

Conflict of Interest: Dr. Stanbrook has nothing to disclose.

Conflict of Interest: Dr. Wong reports that Becton Dickinson (BD) provides funds that help support the advanced pulmonary procedures fellowship at his institution. Cook Medical provides support for simulation courses Dr. Wong runs for pulmonary trainees in Toronto.

Conflict of Interest: Dr. Cram has nothing to disclose.

Conflict of Interest: Dr. Gershon reports grants from Government of Ontario, grants from Canadian Respiratory Research Network, during the conduct of the study; .

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received October 26, 2021.
  • Accepted November 24, 2021.
  • Copyright ©The authors 2021
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 8 Issue 3 Table of Contents
ERJ Open Research: 8 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trends in non-receipt of recommended chronic obstructive pulmonary disease medication
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Trends in non-receipt of recommended chronic obstructive pulmonary disease medication
Michael Poon, Priscila Pequeno, Shawn D. Aaron, Matthew Stanbrook, Harvey Wong, Peter Cram, Andrea S. Gershon
ERJ Open Research Jan 2021, 00584-2021; DOI: 10.1183/23120541.00584-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Trends in non-receipt of recommended chronic obstructive pulmonary disease medication
Michael Poon, Priscila Pequeno, Shawn D. Aaron, Matthew Stanbrook, Harvey Wong, Peter Cram, Andrea S. Gershon
ERJ Open Research Jan 2021, 00584-2021; DOI: 10.1183/23120541.00584-2021
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Two cases of nintedanib-induced diarrhoea treated using a 5-HT type 3 receptor antagonist
  • Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic
  • COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter study
Show more Research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society